# Eraser vs Unlearn.AI

Eraser records 534,396 monthly visits with -23.6% month-over-month growth and Freemium, Paid, Contact for Pricing pricing. Unlearn.AI records 17,107 monthly visits with -32.5% growth and Contact for Pricing pricing.

| Metric | [Eraser](https://openaitools.app/tool/eraser) | [Unlearn.AI](https://openaitools.app/tool/unlearn-ai) |
| :--- | :--- | :--- |
| Website URL | https://www.eraser.io | https://unlearn.ai |
| Categories | AI Diagram Generator, AI Copilot, AI Design Generator, AI Documents Generator | AI Healthcare, AI Research Tool, AI Predictions, AI Models |
| Pricing Model | Freemium, Paid, Contact for Pricing | Contact for Pricing |
| Monthly Visits | 534,396 | 17,107 |
| MoM Growth Rate | -23.6% | -32.5% |
| Primary Market | India | United States |
| Direct Visits | 267,661 | 7,493 |
| Review Score | 4.6 | 4.4 |
| Saved Count | 3 | 1 |
| Supported Platforms | Website | Website |

## Eraser

Eraser is a technical design platform aimed at the people who document architecture: enterprise architects, DevOps and platform engineers, consultants, and software teams. The core promise is speed without sloppiness, so instead of dragging boxes for hours you describe the system or point Eraser at a source of truth such as code, a cloud account, a CMDB, or a spreadsheet, and it produces a diagram that already follows sensible layout rules.

Beyond static images, Eraser supports interactive maps that zoom from a company-wide view down into a single service, guided explainers that walk teammates through a system, and AI documents for design docs and technical documentation. Team governance features such as shared style presets, naming rules, and reference architectures keep output consistent as more people create diagrams. An open-source agent toolkit and MCP server let tools like Claude, Cursor, and ChatGPT create, search, and export diagrams programmatically.

Prices are organized in tiers that include a free entry point, paid plans, and enterprise agreements, with multi-tenant, single-tenant, and self-hosted deployment options for larger organizations. Security posture includes SOC 2 Type 2 certification and SAML SSO.

**Pricing & Plans:** Freemium with paid plans and custom enterprise pricing. A free tier and free tools such as DiagramGPT are available, while paid individual and team plans plus enterprise agreements cover advanced governance, security, and deployment options; check the pricing page for current rates.

- **AI diagram generation:** Generate architecture diagrams, flowcharts, sequence diagrams, and BPMN from a text prompt, code, Terraform, or an uploaded PDF, Word, Excel, PowerPoint, Draw.io, or Visio file.
- **Maps from live systems:** Build interactive maps that sync with cloud accounts, repositories, and internal catalogs so the picture stays close to the real environment, with drill-down from org level to a single container.
- **Diagram-as-code integrations:** Paste code or connect private and public Git repositories, Confluence, Notion, VS Code, and GitHub to keep diagrams grounded in actual implementation.
- **Open-source agent toolkit and MCP server:** Run the agent toolkit in your own infrastructure under an MIT license and let MCP-compatible clients create, search, update, and export diagrams with OAuth or API tokens.
- **Team style governance:** Apply presets, naming and notation rules, and reference architectures so every teammate's diagram ships on-brand and consistent.

**Strengths:** Turns prompts, code, and files into properly laid-out diagrams instead of raw box-and-arrow output; Interactive maps and explainers make complex systems understandable to non-architects; MCP server and open-source toolkit fit agent-driven and self-hosted workflows; Enterprise controls such as SSO, SAML, and SOC 2 Type 2 certification

**Limitations:** Heaviest value comes with team and governance features that need setup; Advanced mapping and self-hosted deployment are aimed at larger organizations rather than solo users

[Profile (Markdown)](https://openaitools.app/tool/eraser.md)

## Unlearn.AI

Unlearn.AI works with biopharma sponsors and clinical research teams at three points in a trial's lifecycle: before the protocol is finalized, while the study is running, and after readout. In design, teams model the patients they expect to enroll and pressure-test sample size, eligibility criteria, endpoints, and comparators before locking the protocol. The company's PROCOVA method — described as EMA-qualified and FDA-supported — applies twin-based covariate adjustment to reduce sample size in randomized controlled trials while holding statistical power, or to increase power without adding patients.

Mid-study, Unlearn supports pre-specified twin-based analyses that tighten interim estimates without enrolling anyone new, and lets teams re-run design scenarios when new evidence — a competitor readout, a fresh publication, or blinded data drifting from assumptions — changes the picture. After a study reads out, digital twins are used to contextualize population, endpoints, and variability, improving sensitivity across endpoints and helping teams re-evaluate historical trial data with regulatory-aligned methods.

Unlearn publishes concrete case outcomes: a 20% sample-size reduction built into a Phase 1/2 design with roughly $2M in savings, a 33% smaller control arm and four-plus months of enrollment time saved in a re-analysis of completed Phase 3 trials from a top-5 global sponsor, and a completed Phase 3 ALS trial re-analyzed to keep full power with 92 fewer participants. The company partners with sponsors including Trace Neuroscience, QurAlis, Acumen Pharmaceuticals, SOLA Biosciences, VectorY Therapeutics, and CHDI Foundation, and states it works with top global pharma companies. Unlearn does not publish list pricing; engagements are scoped through direct contact.

**Pricing & Plans:** Enterprise, contact-for-pricing model. Unlearn does not publish standard subscription tiers; engagements are scoped per study or program after a conversation with the team.

- **AI-generated patient digital twins:** Model-based forecasts of each participant's clinical outcomes, generated from baseline data already collected, that act as a virtual comparator or as additional information per enrolled patient.
- **PROCOVA design and analysis method:** A twin-based covariate adjustment approach that Unlearn describes as EMA-qualified and FDA-supported, used to reduce sample size in randomized controlled trials while maintaining power.
- **Trial design scenario modeling:** Build and compare design scenarios — endpoints, eligibility criteria, sample size, assumptions — so governance decisions are made with quantified tradeoffs instead of positions.
- **Interim and readout analysis support:** Pre-specified twin-based analyses added to the statistical analysis plan before unblinding, plus twin-adjusted analysis delivered at interim and at readout.
- **Externally controlled study design:** Design single-arm and externally controlled studies where randomization is not an option, selecting eligibility criteria that give open-label studies the best chance of a clear readout.

**Strengths:** Digital twins are generated from data already collected, so no extra patients are required to gain information; Publicly reported, quantified outcomes — sample-size reductions, cost savings, and enrollment time saved — rather than only qualitative claims; Covers the whole trial lifecycle: design, interim, and readout, not just one decision point; Named collaborations with biotech and pharma sponsors, plus regulatory-aligned methodology

**Limitations:** Pricing is not published, so budgeting requires a direct sales conversation; The value proposition depends on regulatory acceptance of twin-based methods, which varies by agency and indication; Best suited to sponsors with existing clinical data and statistical teams; not a self-serve tool; Public metrics come from specific studies and may not transfer directly to other indications

[Profile (Markdown)](https://openaitools.app/tool/unlearn-ai.md)

## Frequently Asked Questions

### How do Eraser and Unlearn.AI compare in monthly traffic?

Eraser has 534,396 monthly visits, while Unlearn.AI has 17,107. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

Eraser has a month-over-month growth rate of -23.6%; Unlearn.AI has -32.5%.

### How does pricing compare?

Eraser: Freemium, Paid, Contact for Pricing. Freemium with paid plans and custom enterprise pricing. A free tier and free tools such as DiagramGPT are available, while paid individual and team plans plus enterprise agreements cover advanced governance, security, and deployment options; check the pricing page for current rates. Unlearn.AI: Contact for Pricing. Enterprise, contact-for-pricing model. Unlearn does not publish standard subscription tiers; engagements are scoped per study or program after a conversation with the team.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [Miro](https://openaitools.app/tool/miro) | 30,749,206 | +1.7% | Freemium, Contact for Pricing | Offers an expansive infinite canvas for team brainstorming and visual workshops, but lacks Eraser's code-to-diagram automation. | [.md](https://openaitools.app/tool/miro.md) |
| 2 | [Napkin AI](https://openaitools.app/tool/napkin) | 1,029,978 | -17.5% | Freemium | Automatically embeds visual diagrams directly inside text documents, though it lacks Eraser's specialized cloud architecture focus. | [.md](https://openaitools.app/tool/napkin.md) |
| 3 | [Dr.Oracle](https://openaitools.app/tool/dr-oracle) | 723,847 | -1.2% | Free Trial | Guideline-directed medical answers with citations, built for clinicians | [.md](https://openaitools.app/tool/dr-oracle.md) |
| 4 | [Upheal](https://openaitools.app/tool/upheal-io) | 347,782 | -2.1% | Freemium, Free Trial, Contact for Pricing | AI therapy notes and an AI-native EHR built for mental health professionals. | [.md](https://openaitools.app/tool/upheal-io.md) |
| 5 | [EdrawMax](https://openaitools.app/tool/edrawmax-com) | 301,707 | -6.5% | Paid | Provides extensive drag-and-drop shapes and templates for general diagrams, but weaker automated code-to-diagram capabilities than Eraser. | [.md](https://openaitools.app/tool/edrawmax-com.md) |
| 6 | [Cloudairy](https://openaitools.app/tool/cloudairy) | 179,162 | -13% | Freemium, Contact for Pricing | Combines team whiteboarding, documentation, and diagramming in one platform, but less tailored for automated codebase architecture. | [.md](https://openaitools.app/tool/cloudairy.md) |
| 7 | [ChartDB](https://openaitools.app/tool/chartdb) | 49,523 | -33.4% | Freemium | Open-source tool specifically tailored for database schema visualization and ER diagrams, but lacks general system documentation features. | [.md](https://openaitools.app/tool/chartdb.md) |
| 8 | [Delve AI](https://openaitools.app/tool/delve) | 49,025 | -4.6% | Freemium | Generate data-backed personas, digital twins and synthetic research on demand | [.md](https://openaitools.app/tool/delve.md) |
| 9 | [Mermaid Chart](https://openaitools.app/tool/mermaid-chart) | 46,022 | +519% | Freemium, Free Trial | Stronger focus on standard Mermaid syntax and code-driven diagrams, but lacks Eraser's native autonomous architecture doc generation. | [.md](https://openaitools.app/tool/mermaid-chart.md) |
| 10 | [Oatmeal Health](https://openaitools.app/tool/oatmeal-health) | 40,264 | -44.9% | Contact for Pricing | AI lung cancer screening that finds eligible patients and scores every nodule | [.md](https://openaitools.app/tool/oatmeal-health.md) |

---
Source: https://openaitools.app/compare/eraser-vs-unlearn-ai

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)
